Shanghai INT Medical Instruments Co., Ltd. (HKG:1501)

Hong Kong · Delayed Price · Currency is HKD

30.50

+1.82 (6.35%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Cardiovascular Interventional Business	771.93M	641.32M	497.05M	411.18M	341.29M
Cardiovascular Interventional Business Growth	20.36%	29.03%	20.89%	20.48%	23.25%
Elimination of Inter-Segment Revenue	-83.55M	-48.73M	-44.43M	-28.24M	-14.14M
ALL Others	163.57M	160.24M	133.26M	81.73M	31.27M
ALL Others Growth	2.08%	20.24%	63.05%	161.36%	57.20%
Total	851.95M	752.84M	585.88M	464.68M	358.43M
Total Growth	13.17%	28.50%	26.08%	29.64%	25.12%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Mainland China	599.42M	549.50M	437.34M	361.76M	246.51M
Mainland China Growth	9.08%	25.65%	20.89%	46.75%	28.00%
Europe	50.68M	45.32M	46.92M	26.99M	38.91M
Europe Growth	11.84%	-3.42%	73.85%	-30.63%	21.93%
The United States	55.19M	46.64M	28.16M	18.88M	14.19M
The United States Growth	18.33%	65.62%	49.14%	33.11%	1.19%
Other countries and regions	146.67M	111.38M	73.46M	57.04M	58.82M
Other countries and regions Growth	31.69%	51.62%	28.78%	-3.03%	22.69%
Total	851.95M	752.84M	585.88M	464.68M	358.43M
Total Growth	13.17%	28.50%	26.08%	29.64%	25.12%

Source: S&P Global Market Intelligence.